Fixed Dosing of Monoclonal Antibodies in Oncology

Most monoclonal antibodies in oncology are administered in body–size‐based dosing schedules. This is believed to correct for variability in both drug distribution and elimination between patients. However, monoclonal antibodies typically distribute to the blood plasma and extracellular fluids only,...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncologist
Egile Nagusiak: Hendrikx, Jeroen J.M.A., Haanen, John B.A.G., Voest, Emile E., Schellens, Jan H.M., Huitema, Alwin D.R., Beijnen, Jos H.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: AlphaMed Press 2017
Gaiak:
New Drug Development and Clinical Pharmacology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5634778/
https://ncbi.nlm.nih.gov/pubmed/28754722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0167
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak